Determination of glycine transporter opens new avenues in development of psychiatric drugs

Covid 19: Why we can’t risk another wave
4 March 2021
COVID leaves most pro athletes with no lasting heart damage
4 March 2021

Determination of glycine transporter opens new avenues in development of psychiatric drugs

Glycine can stimulate or inhibit neurons in the brain, thereby controlling complex functions. Unraveling the three-dimensional structure of the glycine transporter, researchers have now come a big step closer to understanding the regulation of glycine in the brain. These results, which have been published in Nature, open up opportunities to find effective drugs that inhibit GlyT1 function, with major implications for the treatment of schizophrenia and other mental disorders.

Comments are closed.